Cite
APA Citation
Hofer, M. D. (2018). lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. Fundamental & clinical pharmacology, 32, 547. http://access.bl.uk/ark:/81055/vdc_100068804991.0x00003e
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hofer, M. D. (2018). lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. Fundamental & clinical pharmacology, 32, 547. http://access.bl.uk/ark:/81055/vdc_100068804991.0x00003e